Ali Ismail Al-Gareeb
← Back to Jabir Ibn Hayyan University for Medical and Pharmaceutical Sciences
Jabir Ibn Hayyan University for Medical and Pharmaceutical Sciences
Ali Ismail Al-Gareeb works in COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Alzheimer's disease research and treatments, Parkinson's Disease Mechanisms and Treatments, Neuroinflammation and Neurodegeneration Mechanisms. Recorded institutional associations include Mustansiriyah University, Jabir Ibn Hayyan University for Medical and Pharmaceutical Sciences.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality
2022 · 189 citationsNephrotoxicity: Role and significance of renal biomarkers in the early detection of acute renal injury
2019 · 180 citationsA review of the bioactive components and pharmacological properties of Lavandula species
2023 · 168 citationsCommiphora myrrh: a phytochemical and pharmacological update
2022 · 153 citationsCOVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
2021 · 130 citationsDepression and type 2 diabetes: A causal relationship and mechanistic pathway
2024 · 122 citationsPathophysiology of Post-COVID syndromes: a new perspective
2022 · 122 citationsSIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close
2022 · 118 citationsCOVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin
2021 · 113 citationsMorus alba: a comprehensive phytochemical and pharmacological review
2023 · 112 citationsA Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease
2022 · 105 citationsThe Looming Effects of Estrogen in Covid-19: A Rocky Rollout
2021 · 105 citationsMetformin role in Parkinson’s disease: a double-sword effect
2023 · 101 citationsTraditional herbs against COVID-19: back to old weapons to combat the new pandemic
2022 · 89 citationsImpact of Sitagliptin on Non-diabetic Covid-19 Patients
2021 · 89 citationsCovid-19-Induced Dysautonomia: A Menace of Sympathetic Storm
2021 · 89 citationsRole of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit
2024 · 86 citationsNF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective
2023 · 86 citationsStatins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review
2022 · 86 citationsThe beneficial role of autophagy in multiple sclerosis: Yes or No?
2023 · 85 citationsPirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals
2022 · 82 citationsPros and cons for statins use and risk of Parkinson's disease: An updated perspective
2023 · 80 citationsCOVID-19 and corticosteroids: a narrative review
2022 · 80 citationsLong-term use of metformin and Alzheimer’s disease: beneficial or detrimental effects
2023 · 77 citationsThe Prospective Effect of Allopurinol on the Oxidative Stress Index and Endothelial Dysfunction in Covid-19
2022 · 77 citations
